Genetic Immunity, InPlay Completes Patient Enrollment In Phase II Trial Of DermaVir Patch HIV Immunotherapeutic Nanomedicine Lead Product Candidate
Jun 14th, 2009 | By buddy1 | Category: Diseases, Disorders, Infections, Health & Wellness NewsPower of the Dream Ventures, Inc. (OTCBB: PWRV), Hungary’s premier technology acquisition and development company, is pleased to present this Genetic Immunity release, based on a previously announced agreement whereby Power of the Dream Ventures will issue communications for Genetic Immunity on a going forward basis.
